Jun 22, 2020
BioInvent and Transgene's BT-001 Achieves Outstanding Tumor Cure Rates in Preclinical Models
Mar 03, 2020
BioInvent and Transgene to Present Data on BT-001, an Oncolytic Virus Encoding for an Anti-CTLA4 Antibody, at Upcoming Congresses
Feb 10, 2020
Origin Agritech Updates GMO Corn Seed Research and Commercialization Strategies
Dec 09, 2019
Kraig Biocraft Laboratories’ Research Team Readies Next Breakthrough in Recombinant Spider Silk Performance
Aug 05, 2019
Genective names Qiaoni Linda Jing as Chief Executive Officer
Mar 26, 2019
BioInvent and Transgene Extend Their Collaboration to Develop Multifunctional Oncolytic Viruses for the Treatment of Solid Tumors
Feb 28, 2019
Trianni, Inc. Announces Issuance of Patent in Japan
Nov 29, 2018
Humanized Liver Mice Model Market is Projected to Account for Over US$ 22.8 Mn in Terms of Value By 2026 End- Persistence Market Research
Sep 04, 2018
SillaJen and Lee's Pharmaceutical Announce First Patient Enrolled in the PHOCUS Trial in China Phase 3 Clinical Trial for Oncolytic Immunotherapy, Pexa-Vec, in Liver Cancer
Aug 31, 2018
North America to Maintain its Lion's Share Through 2023 in the Gene Therapy Market
Jun 21, 2018
Ablexis Targets Market Expansion Opportunities for AlivaMab Mouse Following Acquisition by Deerfield Management and the Founding of AlivaMab Discovery Services
Mar 28, 2018
Trianni, Inc. and NovaRock Biotherapeutics, Ltd. Announce Licensing Agreement
Oct 18, 2017
Trianni and Juno Therapeutics Sign Licensing Agreement for Use of Trianni Transgenic Mouse Platform